Financial Statements and Exhibits


 





 


Exhibit


Number


 




Exhibit Description




Form




File Date






 


10.1†


 




Engagement Agreement dated February 1, 2008 between BioLargo, Inc. and Charles K. Dargan, II




Form 8-K




2/4/2008






 


10.2†


 




Engagement Extension Agreement dated as of February 23, 2020 between BioLargo, Inc. and Charles K. Dargan, II




Form 8-K




2/27/21






 


10.3†*


 




Engagement Ex tension Agreement dated as of March 18, 2021 between BioLargo, Inc. and Charles K. Dargan, II



 


 




 








Management contract or compensatory plan, contract or arrangement






*




Filed herewith





 


SIGNATURES


 


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 


 





Date: March 19, 2021




BIOLARGO, INC.

 




 






 




 




 




 






 




By:




 /s/ 

Dennis P. Calvert




 






 




 




 Dennis P. Calvert




 






 




 




 President and Chief Executive Officer




 





 


 


 


 




 


 





 






makes a similar move, sign up!

Other recent filings from the company include the following:

Major owner of BIOLARGO, INC. just picked up 61,842 shares - Oct. 6, 2021
BIOLARGO, INC. director was just granted 98,684 options - Oct. 5, 2021
BIOLARGO, INC. director was just granted 98,684 options - Oct. 5, 2021
BIOLARGO, INC. director was just granted 78,947 options - Oct. 5, 2021
BIOLARGO, INC. director was just granted 78,947 options - Oct. 5, 2021

Auto Refresh

Feedback